UNC Health Medication Formulary
QR Code Add Formweb to your mobile device
Click here to submit safety event reports via SAFE
UNC Health Medication Formulary

<< Back to News

System Formulary Update
Loncastuximab Tesirine-lpyl (Zynlonta)

Situation

Loncastuximab tesirine-lpyl 10 mg for injection was approved for addition to the health system formulary at the September 2021 System Pharmacy and Therapeutics Committee meeting.

Background

The following medication was reviewed: Loncastuximab tesirine-lpyl 10 mg for injection

Assessment/Recommendation

Change effective: Tuesday, November 9, 2021

System P&T voted to include the following products on the UNC Health Medication Formulary:

  • Loncastuximab tesirine-lpyl 10 mg for injection

Note: Stock of this formulary product may vary at individual entities






This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.